Clinical Trial Update: Cytidine and Omega-3 Fatty Acids in Bipolar Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cytidine in combination with omega-3 fatty acids for bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Cytidine (cytidine)
• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Mclean Hospital | Conditions: Bipolar Disorder | Phase 2 | Status: COMPLETED